These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19198084)

  • 1. [Migrainology learned from patients].
    Sakai F
    Rinsho Shinkeigaku; 2008 Nov; 48(11):785-91. PubMed ID: 19198084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathophysiology of migraine--migraine generator].
    Hamada J
    Rinsho Shinkeigaku; 2008 Nov; 48(11):857-60. PubMed ID: 19198100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adding Additional Acute Medications to a Triptan Regimen for Migraine and Observed Changes in Headache-Related Disability: Results From the American Migraine Prevalence and Prevention (AMPP) Study.
    Buse DC; Serrano D; Reed ML; Kori SH; Cunanan CM; Adams AM; Lipton RB
    Headache; 2015 Jun; 55(6):825-39. PubMed ID: 25881857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trigeminal-Targeted Treatments in Migraine: Is 60% the Magic Number?
    Barbanti P; Egeo G; Mitsikostas DD
    Headache; 2019 Oct; 59(9):1659-1661. PubMed ID: 31508812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosing and managing migraine headache.
    Mueller LL
    J Am Osteopath Assoc; 2007 Nov; 107(10 Suppl 6):ES10-6. PubMed ID: 17986672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recent progress in therapy for migraine headache].
    Iizuka T; Sakai F
    Nihon Naika Gakkai Zasshi; 2004 Feb; 93(2):404-11. PubMed ID: 15007953
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of switching acute treatment on disability in migraine patients using triptans.
    Serrano D; Buse DC; Kori SH; Papapetropoulos S; Cunanan CM; Manack AN; Reed ML; Lipton RB
    Headache; 2013 Oct; 53(9):1415-29. PubMed ID: 23808937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensory neuropeptides (substance P, calcitonin gene-related peptide) and vasoactive intestinal polypeptide in human saliva: their pattern in migraine and cluster headache.
    Nicolodi M; Del Bianco E
    Cephalalgia; 1990 Feb; 10(1):39-50. PubMed ID: 1690601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptides in migraine and cluster headache.
    Edvinsson L; Goadsby PJ
    Cephalalgia; 1994 Oct; 14(5):320-7. PubMed ID: 7828188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated saliva calcitonin gene-related peptide levels during acute migraine predict therapeutic response to rizatriptan.
    Cady RK; Vause CV; Ho TW; Bigal ME; Durham PL
    Headache; 2009 Oct; 49(9):1258-66. PubMed ID: 19788468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a structured migraine diary improves patient and physician communication about migraine disability and treatment outcomes.
    Baos V; Ester F; Castellanos A; Nocea G; Caloto MT; Gerth WC;
    Int J Clin Pract; 2005 Mar; 59(3):281-6. PubMed ID: 15857323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cross-sectional survey to assess the migraineur's medication decision-making beliefs: determining when a migraine is triptan-worthy.
    Landy SH; Turner IM; Runken MC; Lee M; Sulcs E; Bell CF
    Headache; 2013; 53(7):1134-46. PubMed ID: 23773016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Information about migraine disability influences physicians' perceptions of illness severity and treatment needs.
    Holmes WF; MacGregor EA; Sawyer JP; Lipton RB
    Headache; 2001 Apr; 41(4):343-50. PubMed ID: 11318880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between migraine and physical exercise.
    Amin FM; Aristeidou S; Baraldi C; Czapinska-Ciepiela EK; Ariadni DD; Di Lenola D; Fenech C; Kampouris K; Karagiorgis G; Braschinsky M; Linde M;
    J Headache Pain; 2018 Sep; 19(1):83. PubMed ID: 30203180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barriers to the diagnosis and treatment of migraine: effects of sex, income, and headache features.
    Lipton RB; Serrano D; Holland S; Fanning KM; Reed ML; Buse DC
    Headache; 2013 Jan; 53(1):81-92. PubMed ID: 23078241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute treatment of headache.
    Rapoport AM
    J Headache Pain; 2006 Oct; 7(5):355-9. PubMed ID: 17058043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypocretins and primary headaches: neurobiology and clinical implications.
    Rainero I; De Martino P; Pinessi L
    Expert Rev Neurother; 2008 Mar; 8(3):409-16. PubMed ID: 18345971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Headache. Current status of research and treatment].
    Straube A; Gaul C
    Schmerz; 2015 Oct; 29(5):510-5. PubMed ID: 26264901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salivary levels of CGRP and VIP in rhinosinusitis and migraine patients.
    Bellamy JL; Cady RK; Durham PL
    Headache; 2006 Jan; 46(1):24-33. PubMed ID: 16412148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing migraine disability by diary-based measurement: relationship to the characteristics of individual headache attacks.
    Park JW; Shin HE; Kim JS; Lee KS
    Eur J Neurol; 2008 Aug; 15(8):817-21. PubMed ID: 18549394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.